nodes	percent_of_prediction	percent_of_DWPC	metapath
Praziquantel—CYP1A2—Dacarbazine—sarcoma	0.12	0.141	CbGbCtD
Praziquantel—CYP3A7—Vincristine—sarcoma	0.115	0.134	CbGbCtD
Praziquantel—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.115	0.134	CbGbCtD
Praziquantel—CYP3A4—Thiotepa—sarcoma	0.113	0.133	CbGbCtD
Praziquantel—CYP3A5—Vincristine—sarcoma	0.086	0.101	CbGbCtD
Praziquantel—CYP3A5—Etoposide—sarcoma	0.0788	0.0924	CbGbCtD
Praziquantel—CYP1A2—Etoposide—sarcoma	0.0587	0.0688	CbGbCtD
Praziquantel—CYP3A4—Mitoxantrone—sarcoma	0.0487	0.0571	CbGbCtD
Praziquantel—CYP3A4—Vincristine—sarcoma	0.0335	0.0393	CbGbCtD
Praziquantel—CYP2D6—Doxorubicin—sarcoma	0.033	0.0387	CbGbCtD
Praziquantel—CYP3A4—Etoposide—sarcoma	0.0307	0.036	CbGbCtD
Praziquantel—CYP3A4—Doxorubicin—sarcoma	0.021	0.0246	CbGbCtD
Praziquantel—Diarrhoea haemorrhagic—Epirubicin—sarcoma	0.00488	0.0331	CcSEcCtD
Praziquantel—Diarrhoea haemorrhagic—Doxorubicin—sarcoma	0.00451	0.0307	CcSEcCtD
Praziquantel—Drowsiness—Mitoxantrone—sarcoma	0.00148	0.01	CcSEcCtD
Praziquantel—Cardiac disorder—Thiotepa—sarcoma	0.00143	0.00969	CcSEcCtD
Praziquantel—Immune system disorder—Thiotepa—sarcoma	0.00139	0.00943	CcSEcCtD
Praziquantel—Arrhythmia—Thiotepa—sarcoma	0.00137	0.00933	CcSEcCtD
Praziquantel—Bone disorder—Epirubicin—sarcoma	0.00136	0.00927	CcSEcCtD
Praziquantel—Bradycardia—Mitoxantrone—sarcoma	0.00135	0.00918	CcSEcCtD
Praziquantel—Atrioventricular block—Epirubicin—sarcoma	0.00127	0.00863	CcSEcCtD
Praziquantel—Cardiac disorder—Vincristine—sarcoma	0.00126	0.00859	CcSEcCtD
Praziquantel—Bone disorder—Doxorubicin—sarcoma	0.00126	0.00857	CcSEcCtD
Praziquantel—Ill-defined disorder—Dactinomycin—sarcoma	0.00123	0.00837	CcSEcCtD
Praziquantel—Malaise—Dactinomycin—sarcoma	0.0012	0.00813	CcSEcCtD
Praziquantel—Arrhythmia—Mitoxantrone—sarcoma	0.00119	0.00805	CcSEcCtD
Praziquantel—Atrioventricular block—Doxorubicin—sarcoma	0.00118	0.00798	CcSEcCtD
Praziquantel—Convulsion—Thiotepa—sarcoma	0.00116	0.00787	CcSEcCtD
Praziquantel—Myalgia—Thiotepa—sarcoma	0.00114	0.00774	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00113	0.00768	CcSEcCtD
Praziquantel—Myalgia—Dactinomycin—sarcoma	0.00113	0.00768	CcSEcCtD
Praziquantel—Discomfort—Dactinomycin—sarcoma	0.00112	0.00759	CcSEcCtD
Praziquantel—Ill-defined disorder—Mitoxantrone—sarcoma	0.00107	0.00728	CcSEcCtD
Praziquantel—Nervous system disorder—Thiotepa—sarcoma	0.00107	0.00727	CcSEcCtD
Praziquantel—Vertigo—Vincristine—sarcoma	0.00107	0.00724	CcSEcCtD
Praziquantel—Skin disorder—Thiotepa—sarcoma	0.00106	0.0072	CcSEcCtD
Praziquantel—Malaise—Mitoxantrone—sarcoma	0.00104	0.00708	CcSEcCtD
Praziquantel—Anorexia—Thiotepa—sarcoma	0.00104	0.00707	CcSEcCtD
Praziquantel—Anorexia—Dactinomycin—sarcoma	0.00103	0.00702	CcSEcCtD
Praziquantel—Convulsion—Vincristine—sarcoma	0.00103	0.00698	CcSEcCtD
Praziquantel—Cardiac disorder—Etoposide—sarcoma	0.00102	0.00696	CcSEcCtD
Praziquantel—Myalgia—Vincristine—sarcoma	0.00101	0.00686	CcSEcCtD
Praziquantel—Convulsion—Mitoxantrone—sarcoma	0.001	0.0068	CcSEcCtD
Praziquantel—Immune system disorder—Etoposide—sarcoma	0.000997	0.00677	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000995	0.00676	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000987	0.00671	CcSEcCtD
Praziquantel—Myalgia—Mitoxantrone—sarcoma	0.000984	0.00668	CcSEcCtD
Praziquantel—Discomfort—Mitoxantrone—sarcoma	0.000972	0.0066	CcSEcCtD
Praziquantel—Somnolence—Thiotepa—sarcoma	0.000971	0.00659	CcSEcCtD
Praziquantel—Nervous system disorder—Vincristine—sarcoma	0.00095	0.00645	CcSEcCtD
Praziquantel—Decreased appetite—Thiotepa—sarcoma	0.000949	0.00645	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Thiotepa—sarcoma	0.000943	0.0064	CcSEcCtD
Praziquantel—Decreased appetite—Dactinomycin—sarcoma	0.000942	0.0064	CcSEcCtD
Praziquantel—Fatigue—Thiotepa—sarcoma	0.000941	0.00639	CcSEcCtD
Praziquantel—Fatigue—Dactinomycin—sarcoma	0.000934	0.00635	CcSEcCtD
Praziquantel—Anorexia—Vincristine—sarcoma	0.000923	0.00627	CcSEcCtD
Praziquantel—Skin disorder—Mitoxantrone—sarcoma	0.000916	0.00622	CcSEcCtD
Praziquantel—Feeling abnormal—Thiotepa—sarcoma	0.0009	0.00611	CcSEcCtD
Praziquantel—Anorexia—Mitoxantrone—sarcoma	0.000899	0.0061	CcSEcCtD
Praziquantel—Feeling abnormal—Dactinomycin—sarcoma	0.000893	0.00607	CcSEcCtD
Praziquantel—Gastrointestinal pain—Thiotepa—sarcoma	0.000893	0.00606	CcSEcCtD
Praziquantel—Ill-defined disorder—Etoposide—sarcoma	0.000892	0.00606	CcSEcCtD
Praziquantel—Gastrointestinal pain—Dactinomycin—sarcoma	0.000886	0.00602	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Vincristine—sarcoma	0.000882	0.00599	CcSEcCtD
Praziquantel—Urticaria—Thiotepa—sarcoma	0.000868	0.00589	CcSEcCtD
Praziquantel—Malaise—Etoposide—sarcoma	0.000867	0.00589	CcSEcCtD
Praziquantel—Vertigo—Etoposide—sarcoma	0.000864	0.00586	CcSEcCtD
Praziquantel—Body temperature increased—Thiotepa—sarcoma	0.000863	0.00586	CcSEcCtD
Praziquantel—Abdominal pain—Thiotepa—sarcoma	0.000863	0.00586	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000859	0.00584	CcSEcCtD
Praziquantel—Abdominal pain—Dactinomycin—sarcoma	0.000857	0.00582	CcSEcCtD
Praziquantel—Body temperature increased—Dactinomycin—sarcoma	0.000857	0.00582	CcSEcCtD
Praziquantel—Decreased appetite—Vincristine—sarcoma	0.000842	0.00572	CcSEcCtD
Praziquantel—Somnolence—Mitoxantrone—sarcoma	0.000838	0.00569	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Vincristine—sarcoma	0.000836	0.00568	CcSEcCtD
Praziquantel—Fatigue—Vincristine—sarcoma	0.000835	0.00567	CcSEcCtD
Praziquantel—Convulsion—Etoposide—sarcoma	0.000833	0.00566	CcSEcCtD
Praziquantel—Decreased appetite—Mitoxantrone—sarcoma	0.00082	0.00557	CcSEcCtD
Praziquantel—Fatigue—Mitoxantrone—sarcoma	0.000813	0.00552	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000813	0.00552	CcSEcCtD
Praziquantel—Discomfort—Etoposide—sarcoma	0.000808	0.00549	CcSEcCtD
Praziquantel—Hypersensitivity—Thiotepa—sarcoma	0.000805	0.00546	CcSEcCtD
Praziquantel—Hypersensitivity—Dactinomycin—sarcoma	0.000799	0.00542	CcSEcCtD
Praziquantel—Gastrointestinal pain—Vincristine—sarcoma	0.000792	0.00538	CcSEcCtD
Praziquantel—Asthenia—Thiotepa—sarcoma	0.000783	0.00532	CcSEcCtD
Praziquantel—Asthenia—Dactinomycin—sarcoma	0.000778	0.00528	CcSEcCtD
Praziquantel—Feeling abnormal—Mitoxantrone—sarcoma	0.000777	0.00528	CcSEcCtD
Praziquantel—Pruritus—Thiotepa—sarcoma	0.000773	0.00525	CcSEcCtD
Praziquantel—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000771	0.00524	CcSEcCtD
Praziquantel—Eosinophilia—Epirubicin—sarcoma	0.000766	0.0052	CcSEcCtD
Praziquantel—Body temperature increased—Vincristine—sarcoma	0.000765	0.0052	CcSEcCtD
Praziquantel—Abdominal pain—Vincristine—sarcoma	0.000765	0.0052	CcSEcCtD
Praziquantel—Skin disorder—Etoposide—sarcoma	0.000762	0.00517	CcSEcCtD
Praziquantel—Urticaria—Mitoxantrone—sarcoma	0.000749	0.00509	CcSEcCtD
Praziquantel—Anorexia—Etoposide—sarcoma	0.000748	0.00508	CcSEcCtD
Praziquantel—Diarrhoea—Thiotepa—sarcoma	0.000747	0.00507	CcSEcCtD
Praziquantel—Abdominal pain—Mitoxantrone—sarcoma	0.000745	0.00506	CcSEcCtD
Praziquantel—Body temperature increased—Mitoxantrone—sarcoma	0.000745	0.00506	CcSEcCtD
Praziquantel—Diarrhoea—Dactinomycin—sarcoma	0.000742	0.00504	CcSEcCtD
Praziquantel—Dizziness—Thiotepa—sarcoma	0.000722	0.0049	CcSEcCtD
Praziquantel—Hypersensitivity—Vincristine—sarcoma	0.000713	0.00485	CcSEcCtD
Praziquantel—Eosinophilia—Doxorubicin—sarcoma	0.000708	0.00481	CcSEcCtD
Praziquantel—Somnolence—Etoposide—sarcoma	0.000697	0.00474	CcSEcCtD
Praziquantel—Hypersensitivity—Mitoxantrone—sarcoma	0.000695	0.00472	CcSEcCtD
Praziquantel—Asthenia—Vincristine—sarcoma	0.000695	0.00472	CcSEcCtD
Praziquantel—Vomiting—Thiotepa—sarcoma	0.000694	0.00472	CcSEcCtD
Praziquantel—Drowsiness—Epirubicin—sarcoma	0.000689	0.00468	CcSEcCtD
Praziquantel—Vomiting—Dactinomycin—sarcoma	0.000689	0.00468	CcSEcCtD
Praziquantel—Rash—Thiotepa—sarcoma	0.000689	0.00468	CcSEcCtD
Praziquantel—Dermatitis—Thiotepa—sarcoma	0.000688	0.00467	CcSEcCtD
Praziquantel—Headache—Thiotepa—sarcoma	0.000684	0.00465	CcSEcCtD
Praziquantel—Rash—Dactinomycin—sarcoma	0.000683	0.00464	CcSEcCtD
Praziquantel—Decreased appetite—Etoposide—sarcoma	0.000682	0.00463	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Etoposide—sarcoma	0.000677	0.0046	CcSEcCtD
Praziquantel—Asthenia—Mitoxantrone—sarcoma	0.000677	0.0046	CcSEcCtD
Praziquantel—Fatigue—Etoposide—sarcoma	0.000676	0.00459	CcSEcCtD
Praziquantel—Diarrhoea—Vincristine—sarcoma	0.000663	0.0045	CcSEcCtD
Praziquantel—Nausea—Thiotepa—sarcoma	0.000649	0.00441	CcSEcCtD
Praziquantel—Feeling abnormal—Etoposide—sarcoma	0.000646	0.00439	CcSEcCtD
Praziquantel—Diarrhoea—Mitoxantrone—sarcoma	0.000645	0.00438	CcSEcCtD
Praziquantel—Nausea—Dactinomycin—sarcoma	0.000644	0.00437	CcSEcCtD
Praziquantel—Gastrointestinal pain—Etoposide—sarcoma	0.000641	0.00436	CcSEcCtD
Praziquantel—Dizziness—Vincristine—sarcoma	0.00064	0.00435	CcSEcCtD
Praziquantel—Drowsiness—Doxorubicin—sarcoma	0.000638	0.00433	CcSEcCtD
Praziquantel—Bradycardia—Epirubicin—sarcoma	0.00063	0.00428	CcSEcCtD
Praziquantel—Urticaria—Etoposide—sarcoma	0.000623	0.00423	CcSEcCtD
Praziquantel—Abdominal pain—Etoposide—sarcoma	0.00062	0.00421	CcSEcCtD
Praziquantel—Body temperature increased—Etoposide—sarcoma	0.00062	0.00421	CcSEcCtD
Praziquantel—Vomiting—Vincristine—sarcoma	0.000616	0.00418	CcSEcCtD
Praziquantel—Rash—Vincristine—sarcoma	0.000611	0.00415	CcSEcCtD
Praziquantel—Dermatitis—Vincristine—sarcoma	0.00061	0.00414	CcSEcCtD
Praziquantel—Headache—Vincristine—sarcoma	0.000607	0.00412	CcSEcCtD
Praziquantel—Vomiting—Mitoxantrone—sarcoma	0.0006	0.00407	CcSEcCtD
Praziquantel—Rash—Mitoxantrone—sarcoma	0.000595	0.00404	CcSEcCtD
Praziquantel—Dermatitis—Mitoxantrone—sarcoma	0.000594	0.00403	CcSEcCtD
Praziquantel—Headache—Mitoxantrone—sarcoma	0.000591	0.00401	CcSEcCtD
Praziquantel—Bradycardia—Doxorubicin—sarcoma	0.000583	0.00396	CcSEcCtD
Praziquantel—Hypersensitivity—Etoposide—sarcoma	0.000578	0.00392	CcSEcCtD
Praziquantel—Nausea—Vincristine—sarcoma	0.000575	0.00391	CcSEcCtD
Praziquantel—Cardiac disorder—Epirubicin—sarcoma	0.000574	0.0039	CcSEcCtD
Praziquantel—Asthenia—Etoposide—sarcoma	0.000563	0.00382	CcSEcCtD
Praziquantel—Nausea—Mitoxantrone—sarcoma	0.00056	0.0038	CcSEcCtD
Praziquantel—Immune system disorder—Epirubicin—sarcoma	0.000559	0.0038	CcSEcCtD
Praziquantel—Pruritus—Etoposide—sarcoma	0.000555	0.00377	CcSEcCtD
Praziquantel—Arrhythmia—Epirubicin—sarcoma	0.000553	0.00375	CcSEcCtD
Praziquantel—Diarrhoea—Etoposide—sarcoma	0.000537	0.00364	CcSEcCtD
Praziquantel—Cardiac disorder—Doxorubicin—sarcoma	0.000531	0.00361	CcSEcCtD
Praziquantel—Dizziness—Etoposide—sarcoma	0.000519	0.00352	CcSEcCtD
Praziquantel—Immune system disorder—Doxorubicin—sarcoma	0.000517	0.00351	CcSEcCtD
Praziquantel—Arrhythmia—Doxorubicin—sarcoma	0.000512	0.00347	CcSEcCtD
Praziquantel—Ill-defined disorder—Epirubicin—sarcoma	0.0005	0.00339	CcSEcCtD
Praziquantel—Vomiting—Etoposide—sarcoma	0.000499	0.00339	CcSEcCtD
Praziquantel—Rash—Etoposide—sarcoma	0.000495	0.00336	CcSEcCtD
Praziquantel—Dermatitis—Etoposide—sarcoma	0.000494	0.00336	CcSEcCtD
Praziquantel—Headache—Etoposide—sarcoma	0.000491	0.00334	CcSEcCtD
Praziquantel—Malaise—Epirubicin—sarcoma	0.000486	0.0033	CcSEcCtD
Praziquantel—Vertigo—Epirubicin—sarcoma	0.000484	0.00329	CcSEcCtD
Praziquantel—Convulsion—Epirubicin—sarcoma	0.000467	0.00317	CcSEcCtD
Praziquantel—Nausea—Etoposide—sarcoma	0.000466	0.00316	CcSEcCtD
Praziquantel—Ill-defined disorder—Doxorubicin—sarcoma	0.000463	0.00314	CcSEcCtD
Praziquantel—Myalgia—Epirubicin—sarcoma	0.000459	0.00312	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000456	0.00309	CcSEcCtD
Praziquantel—Discomfort—Epirubicin—sarcoma	0.000453	0.00308	CcSEcCtD
Praziquantel—Malaise—Doxorubicin—sarcoma	0.00045	0.00305	CcSEcCtD
Praziquantel—Vertigo—Doxorubicin—sarcoma	0.000448	0.00304	CcSEcCtD
Praziquantel—Convulsion—Doxorubicin—sarcoma	0.000432	0.00293	CcSEcCtD
Praziquantel—Nervous system disorder—Epirubicin—sarcoma	0.000431	0.00293	CcSEcCtD
Praziquantel—Skin disorder—Epirubicin—sarcoma	0.000427	0.0029	CcSEcCtD
Praziquantel—Myalgia—Doxorubicin—sarcoma	0.000424	0.00288	CcSEcCtD
Praziquantel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000421	0.00286	CcSEcCtD
Praziquantel—Discomfort—Doxorubicin—sarcoma	0.000419	0.00285	CcSEcCtD
Praziquantel—Anorexia—Epirubicin—sarcoma	0.000419	0.00285	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000401	0.00272	CcSEcCtD
Praziquantel—Nervous system disorder—Doxorubicin—sarcoma	0.000399	0.00271	CcSEcCtD
Praziquantel—Skin disorder—Doxorubicin—sarcoma	0.000395	0.00268	CcSEcCtD
Praziquantel—Somnolence—Epirubicin—sarcoma	0.000391	0.00265	CcSEcCtD
Praziquantel—Anorexia—Doxorubicin—sarcoma	0.000388	0.00263	CcSEcCtD
Praziquantel—Decreased appetite—Epirubicin—sarcoma	0.000382	0.0026	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Epirubicin—sarcoma	0.00038	0.00258	CcSEcCtD
Praziquantel—Fatigue—Epirubicin—sarcoma	0.000379	0.00257	CcSEcCtD
Praziquantel—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000371	0.00252	CcSEcCtD
Praziquantel—Feeling abnormal—Epirubicin—sarcoma	0.000362	0.00246	CcSEcCtD
Praziquantel—Somnolence—Doxorubicin—sarcoma	0.000362	0.00246	CcSEcCtD
Praziquantel—Gastrointestinal pain—Epirubicin—sarcoma	0.00036	0.00244	CcSEcCtD
Praziquantel—Decreased appetite—Doxorubicin—sarcoma	0.000354	0.0024	CcSEcCtD
Praziquantel—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000351	0.00239	CcSEcCtD
Praziquantel—Fatigue—Doxorubicin—sarcoma	0.000351	0.00238	CcSEcCtD
Praziquantel—Urticaria—Epirubicin—sarcoma	0.000349	0.00237	CcSEcCtD
Praziquantel—Abdominal pain—Epirubicin—sarcoma	0.000348	0.00236	CcSEcCtD
Praziquantel—Body temperature increased—Epirubicin—sarcoma	0.000348	0.00236	CcSEcCtD
Praziquantel—Feeling abnormal—Doxorubicin—sarcoma	0.000335	0.00228	CcSEcCtD
Praziquantel—Gastrointestinal pain—Doxorubicin—sarcoma	0.000333	0.00226	CcSEcCtD
Praziquantel—Hypersensitivity—Epirubicin—sarcoma	0.000324	0.0022	CcSEcCtD
Praziquantel—Urticaria—Doxorubicin—sarcoma	0.000323	0.0022	CcSEcCtD
Praziquantel—Abdominal pain—Doxorubicin—sarcoma	0.000322	0.00218	CcSEcCtD
Praziquantel—Body temperature increased—Doxorubicin—sarcoma	0.000322	0.00218	CcSEcCtD
Praziquantel—Asthenia—Epirubicin—sarcoma	0.000315	0.00214	CcSEcCtD
Praziquantel—Pruritus—Epirubicin—sarcoma	0.000311	0.00211	CcSEcCtD
Praziquantel—Diarrhoea—Epirubicin—sarcoma	0.000301	0.00204	CcSEcCtD
Praziquantel—Hypersensitivity—Doxorubicin—sarcoma	0.0003	0.00204	CcSEcCtD
Praziquantel—Asthenia—Doxorubicin—sarcoma	0.000292	0.00198	CcSEcCtD
Praziquantel—Dizziness—Epirubicin—sarcoma	0.000291	0.00197	CcSEcCtD
Praziquantel—Pruritus—Doxorubicin—sarcoma	0.000288	0.00195	CcSEcCtD
Praziquantel—Vomiting—Epirubicin—sarcoma	0.00028	0.0019	CcSEcCtD
Praziquantel—Diarrhoea—Doxorubicin—sarcoma	0.000278	0.00189	CcSEcCtD
Praziquantel—Rash—Epirubicin—sarcoma	0.000277	0.00188	CcSEcCtD
Praziquantel—Dermatitis—Epirubicin—sarcoma	0.000277	0.00188	CcSEcCtD
Praziquantel—Headache—Epirubicin—sarcoma	0.000275	0.00187	CcSEcCtD
Praziquantel—Dizziness—Doxorubicin—sarcoma	0.000269	0.00183	CcSEcCtD
Praziquantel—Nausea—Epirubicin—sarcoma	0.000261	0.00177	CcSEcCtD
Praziquantel—Vomiting—Doxorubicin—sarcoma	0.000259	0.00176	CcSEcCtD
Praziquantel—Rash—Doxorubicin—sarcoma	0.000257	0.00174	CcSEcCtD
Praziquantel—Dermatitis—Doxorubicin—sarcoma	0.000256	0.00174	CcSEcCtD
Praziquantel—Headache—Doxorubicin—sarcoma	0.000255	0.00173	CcSEcCtD
Praziquantel—Nausea—Doxorubicin—sarcoma	0.000242	0.00164	CcSEcCtD
